Latest Research in Respiratory viral infections research

Top Research Topics in Respiratory viral infections research

• SARS-CoV-2 and COVID-19 Research — 7 papers
• Influenza Virus Research Studies — 5 papers
• Respiratory viral infections research — 4 papers
• Viral Infections and Outbreaks Research — 3 papers
• Viral Infections and Vectors — 2 papers
• Research on Leishmaniasis Studies — 1 papers
• Evolution and Genetic Dynamics — 1 papers
• Tuberculosis Research and Epidemiology — 1 papers
• Vaccine Coverage and Hesitancy — 1 papers
• Viral Infections and Immunology Research — 1 papers

Highest-Cited Papers

1. IL-35 produced by dendritic cells via TIM-3-STAT3 signaling contributes to the development of visceral leishmaniasis
2. Substantial Deceleration of Adaptation of HIV-1 Within 1,500 Generations in an Experimental Evolution: A Genomic Perspective
3. Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV
4. Antigen 85B of Mycobacterium tuberculosis: From Immunodominant Antigen to Vaccine Candidate
5. Anti‐idiotypic antibodies as molecular mimics of conserved influenza hemagglutinin epitopes
6. Complementary Roles of RT-PCR and Next-Generation Sequencing in Post-Vaccination SARS-CoV-2 Infection: Clinical Diagnosis, Genomic Characterization, and Surveillance
7. Non-neutralizing antibody responses control acute Crimean-Congo hemorrhagic fever virus infection in naïve mice
8. Towards Better Vaccines: Enhancing Benefits, Mitigating Risks
9. Dual-antigen AdV5 vaccines against Crimean-Congo hemorrhagic fever virus induce superior humoral and Th1-biased cellular immunity
10. Safety and cross-neutralization capacity of a Sabin strain-based inactivated polio vaccine: a randomized, double-blind, positive-control clinical trial in 2-month-old infants
11. Vaccine-Associated Enhanced Respiratory Disease: From Animal Models to Human Health
12. A bireporter recombinant SARS-CoV-2 Omicron BA.5 for in vitro and in vivo studies
13. Advances in Vaccines Against Infectious Diseases
14. Characterization of Seasonal Trivalent Influenza Vaccine Formulated with Different Ratios (v/v) of Squalene-Containing IB160 Adjuvant in One- or Two-Vial Presentations
15. Intranasal Adenoviral Vector Vaccination Induces Durable Antibody and T Cell Responses in the Respiratory Tract
16. High seroprotection rates among adults 10 years after inactivated Vero cell-derived Japanese encephalitis vaccine, IXIARO
17. Mucosal adjuvant activity of a PAR-2–activating peptide enhances lymph node immune cell recruitment and promotes immune cell activation in a prime–boost influenza vaccination model
18. An Engineered Spike Immunogen Drives Broad Protection of a Bivalent Recombinant Protein COVID-19 Vaccine in Animal Models
19. Broadly reactive antibodies against influenza B virus hemagglutinin neutralize and protect through distinct structural mechanisms
20. EBOLA VIRUS VACCINES AND RECENT ADVANCEMENTS: A SCOPING REVIEW